Drug Licensing

STOCKHOLM, Sweden, July 1, 2026 AlzeCure Pharma AB has announced a landmark global out-licensing and collaboration agreement with Danish...

SAN DIEGO, California, USA, June 2, 2026 Travere Therapeutics has significantly expanded its rare kidney disease pipeline through an...